BCL2L1 and nasopharyngeal carcinoma: Although the effect of inhibiting BCL-2 and MCL-1 was not as pronounced as inhibiting BCL-XL and MCL-1, a combination of ABT-199 and S63845 synergistically inhibited cell proliferation of the NPC cell lines.